RxSight
RxSight®, based in California, is the pioneer in adjustable intraocular lenses, revolutionizing cataract surgery.
Founded
1997RxSight®, based in California, is the pioneer in adjustable intraocular lenses, revolutionizing cataract surgery.
RxSight®, founded in Aliso Viejo, California, is dedicated to transforming the cataract surgery experience. The company's core mission is to revolutionize premium cataract surgery by offering the world's first and only adjustable intraocular lens (IOL) that can be customized post-surgery. Their flagship product, the Light Adjustable Lens™ (LAL®/LAL+™), along with the Light Delivery Device™ (LDD™) system, allows for precise vision adjustments after cataract surgery, catering to patients with corneal astigmatism and without preexisting macular disease.
Notable figures affiliated with RxSight include leading ophthalmologists and industry experts who have contributed to its innovative technology. The company has attracted significant investment from prominent venture capital firms, bolstering its research and development efforts. Key achievements include FDA approval of their adjustable IOL technology and successful commercialization of their products. RxSight's impact on the market is profound, offering a groundbreaking solution that enhances patient outcomes and sets a new standard in cataract surgery.
Companies similar to RxSight include Clearsight, Atia Vision, ReaLens and Sight Sciences.
RxSight was founded in 1997.
RxSight's headquarters is located in Aliso Viejo, CA, US.
RxSight's most recent funding round was for $50M (USD) in February 2023.
As of Feb 7, 2023, RxSight has disclosed funding of $236M (USD). Undisclosed round amounts are excluded.
RxSight has 292 employees as of Feb 6, 2024.
sightsciences.com
